Ignite Creation Date:
2024-05-06 @ 4:33 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05024552
Status:
RECRUITING
Last Update Posted:
2024-06-28
First Post:
2021-08-23
Brief Title:
Vyxeos Plus Gilteritinib in Relapsed or Refractory FLT3-Mutated AML
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Organization Data
Organization:
H Lee Moffitt Cancer Center and Research Institute
Class:
OTHER
Study ID:
MCC-20752
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Jazz Pharmaceuticals | INDUSTRY |